Sort
30,917 grants matching “tumor microenvironment”
Role of Stat3 in tumor immune evasion and immune suppression
$291,277Hua E Yu · Beckman Research Institute/City Of Hope · R01 · FY2009 · CA
Role of Stat3 in tumor immune evasion and immune suppression
$291,277Hua E Yu · Beckman Research Institute/City Of Hope · R01 · FY2008 · CA
Role of Stat3 in tumor immune evasion and immune suppression
$291,277Hua E Yu · Beckman Research Institute/City Of Hope · R01 · FY2007 · CA
Role of Stat3 in tumor immune evasion and immune suppression
$291,277Hua E Yu · Beckman Research Institute/City Of Hope · R01 · FY2010 · CA
Role of Stat3 in modulating tumor microenvironment and angiogenesis
$291,276Hua E Yu · Beckman Research Institute/City Of Hope · R01 · FY2007 · CA
Role of Stat3 in modulating tumor microenvironnment and angiogenesis
$291,276Hua E Yu · Beckman Research Institute/City Of Hope · R01 · FY2010 · CA
Role of Stat3 in modulating tumor microenvironment and angiogenesis
$291,276Hua E Yu · Beckman Research Institute/City Of Hope · R01 · FY2009 · CA
Role of Stat3 in modulating tumor microenvironment and angiogenesis
$291,276Hua E Yu · Beckman Research Institute/City Of Hope · R01 · FY2008 · CA
Vaccination to Enhance T cell Immunotherapy
$291,271Cliona M Rooney · Baylor College Of Medicine · P01 · FY2013 · CA
THE ROLE OF LYMPHOID MICROENVIRONMENT IN AUTOIMMUNITY
$291,236University Of Chicago · R01 · FY2003 · DK
Heparanase regulation of tumor host interactions in myeloma and breast cancer
$291,206Ralph D Sanderson · University Of Alabama At Birmingham · R01 · FY2012 · CA
Heparanase regulation of tumor host interactions in myeloma and breast cancer
$291,204Ralph D Sanderson · University Of Alabama At Birmingham · R01 · FY2011 · CA
Ephrin-A1 in Tumor-Endothelial Interaction During Metastasis
$291,193Jin Chen · Vanderbilt University · R01 · FY2012 · CA
Ephrin-A1 in Tumor-Endothelial Interaction During Metastasis
$291,193Jin Chen · Vanderbilt University · R01 · FY2011 · CA
TGFBI and tumorigenesis
$291,160Xiao-Fan Wang · Duke University · R01 · FY2006 · CA
Molecular mechanism by which Tim-3 induces T cell dysfunction and inhibits anti-t
$291,156Vijay K Kuchroo · Brigham And Women'S Hospital · P01 · FY2016 · AI
Role of Immune Regulatory Pathways in BRAF targeted therapy In melanoma
$291,084Arlene H Sharpe · University Of Tx Md Anderson Can Ctr · U54 · FY2015 · CA
Trajectory and Architecture of Microenvironment-Mediated Resistance in AMLÂ
$291,065Anupriya Agarwal · Oregon Health & Science University · U54 · FY2024 · CA
Translating Improved Pairing and Timing of Drug Combination Strategies
$291,059Brian J Druker · Oregon Health & Science University · U54 · FY2024 · CA
Control of the immune response for cancer vaccine development
$290,975Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
CD4+ Memory T-Cells in Human Lung Tumor Micorenvironment
$290,964Richard B Bankert · State University Of New York At Buffalo · R01 · FY2009 · CA
CD4+ Memory T-Cells in Human Lung Tumor Micorenvironment
$290,964Richard B Bankert · State University Of New York At Buffalo · R01 · FY2008 · CA
CD4+ Memory T-Cells in Human Lung Tumor Micorenvironment
$290,964Richard B Bankert · State University Of New York At Buffalo · R01 · FY2007 · CA
Leveraging Mammalian Cancers, Platinum-Quality Genome Assemblies, and Large-Scale Data to Identify Mechanisms of Rare Human Cancers
$290,921Kiley Graim · University Of Florida · R01 · FY2023 · CA
Cell mediated immunity in mammary tumor models
$290,891Diana M Lopez · University Of Miami School Of Medicine · R01 · FY2007 · CA